Ecadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients

E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients

18:36 EDT 23 Jun 2019 | Nature Publishing

More From BioPortfolio on "E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients"